Help us understand how endometriosis impacts long-term cardiovascular health
If you are a woman (18 – 45 years old) with endometriosis, you may be eligible to participate in a free and confidential study designed to look at how estrogen may affect cardiovascular health.
Minority women are encouraged to participate as it is important to study different groups of people to understand what treatments work best for most women.
Participation requires three in-person visits to the John B. Pierce Lab, including one screening visit (~1 hour) and two experimental visits (~5 hours each).
Compensation up to $380.
To learn more or to see if you are eligible to participate, please email Abby at endoresearch@jbpierce.org.
Sponsored by the National Institutes of Health, National Heart Lung, and Blood Institute; HIC#: 2000022193
Have you had a stroke and have high blood pressure?
We are looking for 8-10 patients with stroke and high blood pressure who are interested in serving on a Patient Advisory Board that will help guide efforts to improve blood pressure control among patients with stroke. Caregivers are also invited to participate. Please reach out if you are interested and if you would like additional information.
Bank of America pre-paid debit card of $50 per meeting.
To learn more or to see if you are eligible to participate, please contact us at (203) 215-9832 or email: Rachel.Forman@yale.edu
Sponsored by: Merck Sharp & Dohme LLC; National Institute of Allergy and Infectious Diseases (NIAID); National Institute of Mental Health (NIMH); Yale University School of Medicine; HIC# 1502015318
Do you or someone you know suffer from Chronic Limb-Threatening Ischemia (CLTI) – also known as Critical Limb Ischemia (CLI)?
If you're 18 or over and have been diagnosed with CLTI, don't respond to available treatments, have no option of revascularization, and are in high risk of leg amputation, then you may be eligible to join a free and confidential study investigating an innovative cell-therapy treatment that can potentially provide amputation-free survival for no-option CLTI patients.
After you have gone through the initial screening process for your enrollment in the trial, your next visit to the clinic will involve a simple blood draw. Three days later - the cells taken from your blood will be re-injected through a simple and rapid procedure followed by overnight inpatient monitoring.
To learn more or to see if you are eligible to participate, please call the research team for the study at 203-785-2561 or email Hugh.Medvecky@yale.edu.
Sponsored by BioGenCell Ltd.; HIC# 2000032326